Methods and materials for identifying and treating membranous nephropathy
US-2024353404-A1 · Oct 24, 2024 · US
Antibodies to hepatocyte growth factor activator
US8969528B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969528-B2 |
| Application number | US-201313765625-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 12, 2013 |
| Priority date | Oct 4, 2004 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides methods and compositions for modulating hepatocyte growth factor activator function.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated antibody that specifically binds human hepatocyte growth factor activator, wherein the antibody comprises (a) a heavy chain variable region comprising: (i) a CDR-H1 sequence comprising the sequence of SEQ ID NO:12; (ii) a CDR-H2 sequence comprising the sequence of SEQ ID NO:13; and (iii) a CDR-H3 sequence comprising the sequence of SEQ ID NO:14; and (b) a light chain variable region comprising CDR L1, L2, and L3 sequences as d…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C07K16/40Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8969528B2 cover?
- The invention provides methods and compositions for modulating hepatocyte growth factor activator function.
- Who is the assignee on this patent?
- Genentech Inc, Genentech Inc
- What technology area does this patent fall under?
- Primary CPC classification C07K16/40. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).